These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 17387571

  • 1. Gallbladder mass with a carbohydrate antigen 19-9 level in the thousands: malignant or benign pathology? Report of a case.
    Clarke T, Matsuoka L, Jabbour N, Mateo R, Genyk Y, Selby R, Gagandeep S.
    Surg Today; 2007; 37(4):342-4. PubMed ID: 17387571
    [Abstract] [Full Text] [Related]

  • 2. Tumor biomarkers: help or mislead in the diagnosis of xanthogranulomatous cholecystitis?-analysis of serum CA 19-9, carcinoembryonic antigen, and CA 12-5.
    Yu H, Yu TN, Cai XJ.
    Chin Med J (Engl); 2013 Aug; 126(16):3044-7. PubMed ID: 23981609
    [Abstract] [Full Text] [Related]

  • 3. [A case of cholangiocarcinoma suspected by continuous elevation of CA 19-9 after surgery of xanthogranulomatous cholecystitis].
    Hwang SY, Kim JS, Jeong JB, Kim JW, Kim BG, Lee KL, Ahn YJ, Chang MS.
    Korean J Gastroenterol; 2010 Jun; 55(6):404-9. PubMed ID: 20571310
    [Abstract] [Full Text] [Related]

  • 4. Mirizzi syndrome caused by xanthogranulomatous cholecystitis: report of a case.
    Lee KC, Yamazaki O, Horii K, Hamba H, Higaki I, Hirata S, Inoue T.
    Surg Today; 1997 Jun; 27(8):757-61. PubMed ID: 9306594
    [Abstract] [Full Text] [Related]

  • 5. Xanthogranulomatous cholecystitis: Difficulty in differentiating from gallbladder cancer.
    Suzuki H, Wada S, Araki K, Kubo N, Watanabe A, Tsukagoshi M, Kuwano H.
    World J Gastroenterol; 2015 Sep 21; 21(35):10166-73. PubMed ID: 26401081
    [Abstract] [Full Text] [Related]

  • 6. Increased serum CA19-9 in patients with xanthogranulomatous cholecystitis.
    Adachi Y, Iso Y, Moriyama M, Kasai T, Hashimoto H.
    Hepatogastroenterology; 1998 Sep 21; 45(19):77-80. PubMed ID: 9496491
    [Abstract] [Full Text] [Related]

  • 7. Diagnosis and treatment of xanthogranulomatous cholecystitis: a report of 39 cases.
    Han SH, Chen YL.
    Cell Biochem Biophys; 2012 Nov 21; 64(2):131-5. PubMed ID: 22707297
    [Abstract] [Full Text] [Related]

  • 8. Mass-forming xanthogranulomatous cholecystitis masquerading as gallbladder cancer.
    Agarwal AK, Kalayarasan R, Javed A, Sakhuja P.
    J Gastrointest Surg; 2013 Jul 21; 17(7):1257-64. PubMed ID: 23615807
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Is xanthogranulomatous cholecystitis the most difficult for laparoscopic cholecystectomy?
    Kim JH, Jeong IH, Yoo BM, Kim JH, Kim MW, Kim WH.
    Hepatogastroenterology; 2009 Jul 21; 56(91-92):597-601. PubMed ID: 19621662
    [Abstract] [Full Text] [Related]

  • 12. Xanthogranulomatous inflammatory strictures of extrahepatic biliary tract: presentation and surgical management.
    Krishna RP, Kumar A, Singh RK, Sikora S, Saxena R, Kapoor VK.
    J Gastrointest Surg; 2008 May 21; 12(5):836-41. PubMed ID: 18266047
    [Abstract] [Full Text] [Related]

  • 13. Surgical procedures and histopathologic findings for patients with xanthogranulomatous cholecystitis.
    Kwon AH, Matsui Y, Uemura Y.
    J Am Coll Surg; 2004 Aug 21; 199(2):204-10. PubMed ID: 15275874
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Elevated CA19-9 levels; not always cancer].
    Haring MPD, de Cort BA, Nieuwenhuijs VB.
    Ned Tijdschr Geneeskd; 2021 Mar 02; 164():. PubMed ID: 33651490
    [Abstract] [Full Text] [Related]

  • 16. A Rare Pathology of Difficult Laparoscopic Cholecystectomy: Xanthogranulomatous Cholecystitis.
    Milkhu CS, Jarral F, Raw D, Maliyakkal A, Fadra A, Shiwani MH.
    J Coll Physicians Surg Pak; 2018 Apr 02; 28(4):330-331. PubMed ID: 29615182
    [Abstract] [Full Text] [Related]

  • 17. Xanthogranulomatous cholecystitis mimicking gallbladder carcinoma: An analysis of 42 cases.
    Deng YL, Cheng NS, Zhang SJ, Ma WJ, Shrestha A, Li FY, Xu FL, Zhao LS.
    World J Gastroenterol; 2015 Nov 28; 21(44):12653-9. PubMed ID: 26640342
    [Abstract] [Full Text] [Related]

  • 18. Diagnosis and treatment of xanthogranulomatous cholecystitis.
    Yabanoglu H, Aydogan C, Karakayali F, Moray G, Haberal M.
    Eur Rev Med Pharmacol Sci; 2014 Nov 28; 18(8):1170-5. PubMed ID: 24817291
    [Abstract] [Full Text] [Related]

  • 19. Caution in interpretation of the tumor marker CA 19.9 in patients with obstructive jaundice: illustrative case reports.
    Helling TS.
    J Miss State Med Assoc; 2013 Apr 28; 54(4):96-9. PubMed ID: 23767270
    [Abstract] [Full Text] [Related]

  • 20. Xanthogranulomatous cholecystitis expressing high levels of DUPAN-II.
    Uwagawa T, Misawa T, Nojiri T, Kitajima K, Kawakami M, Yanaga K.
    J Gastroenterol; 2007 Jul 28; 42(7):593-6. PubMed ID: 17653657
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.